UnitedHealth Group has faced challenges with rising medical costs, missed expectations, and a 30% decline in trading this year. Despite this, its low valuation presents a buying opportunity for long-term investors. Its forward P/E multiple of 20 is below the S&P 500 average, providing a margin of safety.

As UnitedHealth Group prepares to report its third-quarter earnings on Oct. 28, investors are watching closely. The stock’s recent rally could continue or reverse depending on the results. Despite concerns about billing practices and leadership changes, the company maintains a strong business outlook with adjusted earnings per share projected at $16 for the full year.

For investors considering UnitedHealth Group, it’s worth noting that the Motley Fool Stock Advisor team did not include it in their list of the 10 best stocks to buy now. While the stock may offer long-term potential at a discounted price, other opportunities with greater growth potential have been identified by the analyst team.

Read more at Yahoo Finance: 1 Reason to Buy UnitedHealth Group Stock Before Oct. 28